Forty-one surgical patients at risk of deep venous thrombosis (DVT) were treated with defibrotide (400 mg/b.i.d./i.v.) or with heparin (5000 UI/t.i.d./s.c.). Neither DVT nor pulmonary embolism was evidenced. In the heparin group the healing rate was longer and during the first three days bleeding from the surgical wound was more pronounced. In particular one patient of the heparin group had to interrupt the treatment for haemorrhage.
DEFIBROTIDE ED EPARINA NELLA PROFILASSI DELLE TROMBOSI VENOSE PROFONDE. STUDIO CONTROLLATO / Villani, L. G.; DALLA VALLE, Raffaele; Rubini, P.. - In: MINERVA CHIRURGICA. - ISSN 0026-4733. - 45:(1990), pp. 1029-1033.
DEFIBROTIDE ED EPARINA NELLA PROFILASSI DELLE TROMBOSI VENOSE PROFONDE. STUDIO CONTROLLATO
DALLA VALLE, Raffaele;P. Rubini
1990-01-01
Abstract
Forty-one surgical patients at risk of deep venous thrombosis (DVT) were treated with defibrotide (400 mg/b.i.d./i.v.) or with heparin (5000 UI/t.i.d./s.c.). Neither DVT nor pulmonary embolism was evidenced. In the heparin group the healing rate was longer and during the first three days bleeding from the surgical wound was more pronounced. In particular one patient of the heparin group had to interrupt the treatment for haemorrhage.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
